N-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-6-(4,5-dihydro-1,3-oxazol-2-ylmethyl)quinazolin-4-amine
C22H18ClN5O2S — CID 152859736
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-6-(4,5-dihydro-1,3-oxazol-2-ylmethyl)quinazolin-4-amine
N-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-6-(4,5-dihydro-1,3-oxazol-2-ylmethyl)quinazolin-4-amine (PubChem CID 152859736) has the molecular formula C22H18ClN5O2S and a molecular weight of 451.94 g/mol. Its IUPAC name is N-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-6-(4,5-dihydro-1,3-oxazol-2-ylmethyl)quinazolin-4-amine.
Molecular Properties
| Compound Name | N-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-6-(4,5-dihydro-1,3-oxazol-2-ylmethyl)quinazolin-4-amine |
|---|---|
| PubChem CID | 152859736 |
| Molecular Formula | C22H18ClN5O2S |
| Molecular Weight | 451.94 g/mol |
| Exact Mass | 451.09 |
| IUPAC Name | N-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-6-(4,5-dihydro-1,3-oxazol-2-ylmethyl)quinazolin-4-amine |
| SMILES | Clc1cc(Nc2ncnc3ccc(CC4=NCCO4)cc23)ccc1OCc1nccs1 |
| InChI | InChI=1S/C22H18ClN5O2S/c23-17-11-15(2-4-19(17)30-12-21-25-6-8-31-21)28-22-16-9-14(10-20-24-5-7-29-20)1-3-18(16)26-13-27-22/h1-4,6,8-9,11,13H,5,7,10,12H2,(H,26,27,28) |
| InChIKey | TXHAXTYHOXJSSR-UHFFFAOYSA-N |
| XLogP | 5.03 |
| TPSA | 81.52 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 451.94 |
| LogP ≤ 5 | 5.03 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 152859736 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.